ZTS vs BMY

	ZTS Zoetis Inc.	BMY Bristol Myers Squibb Co
Price	$81.03	$61.48
Sector	Health Care	Health Care
X-Ray Score	69	60
Valuation	89	87
Growth	48	33
Profitability	72	58
Financial health	60	57
Dividends	69	55
Fair value	$111	$76
Verdict	Undervalued +35%	Undervalued +21%
Revenue (TTM)	$9.5B	$49.2B
Operating margin	36.9%	27.7%
Return on capital	26.7%	19.3%
Revenue growth (3y)	5.4%	1.4%
Free-cash-flow yield	6.8%	8.9%
Net debt / EBITDA	1.8×	2.0×
Dividend yield	2.5%	4.0%

Scores and fair values are model estimates from SEC filings, ranked within each company's own sector, so scores of companies in different sectors are not directly comparable. Educational only, not financial advice.